Phase II-trial of Concomitant Hyperfractionated-accelerated Radiotherapy (HART) With Cisplatin (Cis) Plus Cetuximab (Cet) for Locoregionally Advanced Inoperable Squamous Cell Head and Neck Cancer - Early Response and Acute Toxicities

Kuhnt, T. and Schreiber, A. and Pirnasch, A. and Hipp, M. and Hass, P. and Sieker, F. and Engenhart-Cabillic, R. and Richter, M. and Dellas, K. and Dunst, J. (2011) Phase II-trial of Concomitant Hyperfractionated-accelerated Radiotherapy (HART) With Cisplatin (Cis) Plus Cetuximab (Cet) for Locoregionally Advanced Inoperable Squamous Cell Head and Neck Cancer - Early Response and Acute Toxicities. EUROPEAN JOURNAL OF CANCER, 47 (Suppl1). S543. ISSN 0959-8049

Full text not available from this repository.
Item Type: Article
Subjects: 600 Technology > 610 Medical sciences Medicine
Divisions: Medicine > Lehrstuhl für Strahlentherapie
Depositing User: Petra Gürster
Date Deposited: 05 May 2020 07:32
Last Modified: 05 May 2020 07:32
URI: https://pred.uni-regensburg.de/id/eprint/20229

Actions (login required)

View Item View Item
pred is powered by EPrints 3.4 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.